Stetler-Stevenson M - Search Results

1

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.

Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Molldrem JJ, et al. Br J Haematol. 1998 Sep;102(5):1314-22. doi: 10.1046/j.1365-2141.1998.00920.x. Br J Haematol. 1998. PMID: 9753062 Free article.

2

Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features.

Saunthararajah Y, Molldrem JL, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L, Young NS, Barrett JA. Saunthararajah Y, et al. Br J Haematol. 2001 Jan;112(1):195-200. doi: 10.1046/j.1365-2141.2001.02561.x. Br J Haematol. 2001. PMID: 11167802 Free article.

3

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.

Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Stetler-Stevenson M, et al. Blood. 2001 Aug 15;98(4):979-87. doi: 10.1182/blood.v98.4.979. Blood. 2001. PMID: 11493442 Free article.

4

Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.

Hardy NM, Grady C, Pentz R, Stetler-Stevenson M, Raffeld M, Fontaine LS, Babb R, Bishop MR, Caporaso N, Marti GE. Hardy NM, et al. Br J Haematol. 2007 Dec;139(5):824-31. doi: 10.1111/j.1365-2141.2007.06862.x. Br J Haematol. 2007. PMID: 18021093 Free article.

5

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy.

Jiang L, Yuan CM, Hubacheck J, Janik JE, Wilson W, Morris JC, Jasper GA, Stetler-Stevenson M. Jiang L, et al. Br J Haematol. 2009 Apr;145(2):173-9. doi: 10.1111/j.1365-2141.2009.07606.x. Epub 2009 Feb 19. Br J Haematol. 2009. PMID: 19236377 Free PMC article.

6

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.

Mussai F, Campana D, Bhojwani D, Stetler-Stevenson M, Steinberg SM, Wayne AS, Pastan I. Mussai F, et al. Br J Haematol. 2010 Aug;150(3):352-8. doi: 10.1111/j.1365-2141.2010.08251.x. Epub 2010 Jun 7. Br J Haematol. 2010. PMID: 20528877 Free PMC article.

7

Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.

Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE. Sportès C, et al. Clin Cancer Res. 2010 Jan 15;16(2):727-35. doi: 10.1158/1078-0432.CCR-09-1303. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068111 Free PMC article. Clinical Trial.

8

T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.

Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN. Ali SA, et al. Blood. 2016 Sep 29;128(13):1688-700. doi: 10.1182/blood-2016-04-711903. Epub 2016 Jul 13. Blood. 2016. PMID: 27412889 Free PMC article. Clinical Trial.

9

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN. Brudno JN, et al. J Clin Oncol. 2018 Aug 1;36(22):2267-2280. doi: 10.1200/JCO.2018.77.8084. Epub 2018 May 29. J Clin Oncol. 2018. PMID: 29812997 Free PMC article.

10

'A novel approach for characterisation of KSHV-associated multicentric Castleman disease from effusions': Response.

Zhou T, Yuan CM, Lurain K, Stetler-Stevenson M, Filie AC, Pittaluga S, Jaffe ES, Ramaswami R, Yarchoan R, Wang HW. Zhou T, et al. Among authors: stetler stevenson m. Br J Haematol. 2023 Apr;201(2):360-363. doi: 10.1111/bjh.18699. Epub 2023 Feb 16. Br J Haematol. 2023. PMID: 36794595 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page